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Endosomal sorting is a highly orchestrated cellular process.
Retromer is a heterotrimeric complex that associateswith endo-
somal membranes and facilitates the retrograde sorting of mul-
tiple receptors, including the cation-independent mannose
6-phosphate receptor for lysosomal enzymes. The cycling of ret-
romer on and off the endosomal membrane is regulated by a
network of retromer-interacting proteins. Here, we find that
Parkinson disease-associated Vps35 variant, R524W, but not
P316S, is a loss-of-function mutation as marked by a reduced
association with this regulatory network and dysregulation of
endosomal receptor sorting. Expression of Vps35 R524W-con-
taining retromer results in the accumulation of intracellular
-synuclein-positive aggregates, a hallmark of Parkinson dis-
ease. Overall, the Vps35 R524W-containing retromer has a
decreased endosomal association, which can be partially res-
cued by R55, a small molecule previously shown to stabilize the
retromer complex, supporting the potential for future targeting
of the retromer complex in the treatment of Parkinson disease.
Parkinson disease (PD)4 primarily affects the dopaminergic
neurons of the substantia nigra pars compacta, a small anatom-
ical region located within the midbrain that regulates move-
ment. On a cellular level, PD is a complex disease characterized
by the subcellular formation of large, perinuclear accumula-
tions of aggregated proteins, called Lewy bodies (LBs). The
most abundant protein found in LBs is the presynaptic plasma
membrane-associated protein -synuclein, but they may also
contain other proteins and lipids (1–3). The formation of LBs,
which individual neurons are unable to clear, has been directly
linked to activation of apoptotic pathways in the dopaminergic
neurons (2).
Rare familialmutations in a range of proteins have been iden-
tified and have provided significant insight into the molecular
pathways involved in the manifestation of PD (reviewed in Ref.
4). Recently, a number of point mutations (D620N, P316S,
R524W, and L774M) within the retromer subunit Vps35 (vac-
uolar protein sorting 35) were associated with late onset PD,
and analysis of 144 individuals confirmed that overall levels of
Vps35 mRNA in the substantia nigra were significantly
decreased in PD-affected patients (5–7). Retromer is a hetero-
trimeric complex composed of Vps29, Vps35, and one of the
twoVps26 subunits, Vps26AorVps26B (8–10). Retromer has a
central role in the sorting of receptor cargo within endosomal
membranes, which is essential to coordinate the specific spatio-
temporal localization of individual receptors, enabling them to
perform their varied functions (11, 12). One such cargo is the
cation-independent mannose 6-phosphate receptor (CI-
M6PR) that controls the sorting of lysosomal enzymes, such as
cathepsin D, which is required for protein turnover (11–13).
Retromer serves as a multifunctional scaffold forming an inter-
action hub for a wide array of endosome-associated proteins,
collectively termed the retromer interactome. These interac-
tions aid in the formation of the cargo-containing tubulove-
sicular membrane carriers destined for other compartments,
such as theGolgi apparatus and plasmamembrane. The diverse
proteins that associate with retromer include regulatory mole-
cules, proteins required for membrane recruitment, and pro-
tein complexes that control membrane tubulation and scission
(reviewed in Refs. 14 and 15). It is the spatial and temporal
coordination of the interactions between the retromer and ret-
romer interactome that enables it to coordinate multiple endo-
some-derived trafficking pathways (16).
Characterization of the PD-causing Vps35 D620N mutation
demonstrated that Vps35 D620N-retromer is unable to cor-
rectly traffic cargoes, such as CI-M6PR and post-synaptic
AMPA receptors, the former of which results in improper pro-
cessing and trafficking of cathepsin D (17, 18). Moreover, pre-
vious reports suggest that the aforementioned sorting defect
may arise from perturbed interactions with the WASH com-
plex, a protein complex implicated in endosome-to-Golgi
receptor sorting, and, consequently, may lead to a down-regu-
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lation of autophagy (19–21). Together, these studies support
the importance of the late endocytic network in the degradation
of cellular proteins and highlight the importance of a specific
protease, cathepsin D, in overall lysosomal function and the
degradation of luminal -synuclein.
Here, we report the cellular characterization of two familial
PD-linked Vps35 variants, Vps35 P316S and Vps35 R524W.
Whereas the P316S variant appears to have little impact on
retromer assembly or function, Vps35 R524W is poorly
recruited to endosomes and impairs the recruitment of retro-
mer-dependent interacting proteins and the trafficking of
CI-M6PR. Similar to that observed for Vps35 D620N, expres-
sion of Vps35 R524W induced higher levels of -synuclein-
positive aggregates when compared with that of Vps35 WT or
Vps35 P316S. These findings provide insight into the underly-
ing molecular mechanism of PD-linked Vps35 R524W and ret-
romer’s involvement in themolecular pathways associatedwith
PD.
Results
Vps35 P316S and Vps35 R524WAre Incorporated into Retro-
mer Complexes—To determine whether the formation of the
heterotrimeric retromer complex in the presence of Vps35
variants P316S and R524W is altered, in vitro isothermal titra-
tion calorimetry (ITC) and in vivo co-immunoprecipitation
were employed using full-length recombinant Vps35 proteins
and GFP fusion constructs, respectively. The arginine 524 res-
idue is present in an exposed loop between -helices of the
reiterating pairs of HEAT-like -helical repeats and contrib-
utes indirectly to the VPS35 interface with VPS29, as shown in
the co-crystal structure (22). The proline 316 residue is pre-
dicted to be within an intervening loop, so its substitution is
unlikely to disrupt the overall Vps35 structure. As demon-
strated by ITC, Vps35 P316S retained interaction with retro-
mer subunits Vps26A and Vps29 (Kd 1.5 and 170 nM, respec-
tively) at thermodynamic profiles similar to that of wild-type
Vps35 (Kd 1.1 and 250 nM, respectively). The Vps35 R524W
mutant also demonstrated a binding affinity similar to that
of the wild-type Vps35 for Vps29 (Kd  303 nM) and Vps26A
(Kd 1.4 nM) (Fig. 1A). In support of these in vitro experiments,
co-immunoprecipitation from HeLa cells transiently express-
ing GFP fusion constructs demonstrated that Vps35 P316S and
Vps35 R524W interact with retromer subunits Vps26A and
Vps29 in whole cell lysates or the cytosolic fraction (Fig. 1, B
and C). The incorporation of the PD-associated variants of
Vps35 into Vps26A-retromer complexes was confirmed by co-
immunoprecipitation of endogenous Vps26A (Fig. 1D). Collec-
tively, these data demonstrate that both PD-associated muta-
tions can form stable retromer trimers, and their expression
does not alter steady state protein levels of endogenous retro-
mer subunits. However, comparison of the relative amounts of
the retromer subunits co-precipitated indicates that a portion
of Vps35 R524W does not appear to be complexed to Vps26A
and Vps29.
Vps35 R524W-containing Retromer Has Diminished Endo-
some Recruitment—The subcellular localization of Vps35
P316S and Vps35 R524W was determined in HeLa cells tran-
siently expressing Vps35 WT-GFP, Vps35 P316S-GFP, or
Vps35 R524W-GFP. Consistent with the subcellular localiza-
tion of Vps35 WT-GFP, Vps35 P316S-GFP demonstrated a
high level of endosomal recruitment and displayed a high level
of co-localization with Vps26A on these endosomes (Fig. 2A).
In contrast to this, whereas Vps35 R524W-GFP showed partial
endosomal recruitment, where it co-localized with Vps26A, a
significant fraction of the protein also showed a diffuse local-
ization to the cytosol (Fig. 2A).
Membrane fractionation was employed to determine the rel-
ative proportion of retromer associatedwithmembranes. HeLa
cells transiently transfected with GFP fusion constructs were
lysed in sucrose-containing buffer, and cytosolic and micro-
some fractionswere isolated. Loading controls and purity of the
fractions were monitored using late endosomemarker LAMP1
(microsome) and -tubulin (cytoplasmic). Consistent with the
previously described data, wild-type retromer proteins, includ-
ing Vps35 WT-GFP, were observed associated with mem-
branes and within the cytosol. Vps35 P316S-GFP showed a
distribution similar to Vps35 WT-GFP, whereas Vps35
R524W-GFPwas predominantly distributed in the cytosol with
a proportional decrease in the protein associated with mem-
branes. Further, Western blotting of endogenous Vps26A,
Vps35, and Vps29 demonstrated no significant shift in total
levels of retromer from the microsomal fraction following
expression of the GFP fusion constructs (Fig. 2B). The bio-
chemical and immunofluorescence findings together suggest
impaired endosome association of Vps35 R524W.
We employed confocal microscopy to further examine the
endosome morphology and retromer localization in the pres-
ence of Vps35 P316S and Vps35 R524W (Fig. 2C). HeLa cells
transiently expressing GFP fusion constructs were immunola-
beled with antibodies against early endosomemarker, EEA1, or
late endosomal marker, LAMP1. Consistent with the expres-
sion of Vps35WT-GFP, confocal microscopy revealed recruit-
ment of Vps35 P316S-GFP to EEA1-positive endosomes (RWT
0.2130 and RP316S  0.2013; Fig. 2D), whereas cells expressing
Vps35 R524W-GFP demonstrated reduced overlap with EEA1-
positive compartments (RR524W  0.1551; Fig. 2D). However,
no differences in themorphology of EEA1-positive endosomes,
when compared with neighboring untransfected cells, were
observed in transfected cells expressing any of the Vps35 pro-
teins (Fig. 2C). Immunolabeling of HeLa cells with antibodies
against LAMP1 revealed no gross morphological changes of
late endosome compartments in cells expressing Vps35 WT-
GFP or Vps35 P316S-GFP. In contrast, expression of Vps35
R524W induced some swelling of the late endosome but did not
influence the overall localization of LAMP1-positive compart-
ments when compared with neighboring untransfected cells
(Fig. 2C). Further, consistent with previous observations,
LAMP1 displayed minor overlap with Vps35 WT-GFP, Vps35
P316S-GFP, and Vps35 R524W-GFP (RWT 0.0330, RP316S
0.0518, and RR524W 0.0428, respectively; Fig. 2D).
Subcellular Localization of Vps35 Mutants Using Ascorbate
Peroxidase (APEX)-GFP-binding peptide (GBP)—To resolve
the redistribution of Vps35 generated by the various point
mutations at a higher resolution, we utilized a modified APEX
tag for characterizing subcellular protein distribution with
electron microscopy. Recently, a genetically encoded plasmid
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formodular detection of anyGFP-tagged protein of interest has
been developed that employs co-transfection of APEX directly
conjugated to a GBP (23). When APEX-GBP is expressed, it
binds to the GFP-tagged protein, resulting in the formation of
specific electron density at the site of the protein after the
diaminobenzoic acid reaction in the presence of H2O2 and
post-fixation with osmium tetroxide (23). Control expression
of APEX-GBP alone and APEX-GBP GFP resulted in signif-
icant electron density in the cytoplasm of transfected cells but
no enriched electron density at endosomes/multivesicular bod-
ies (Fig. 3, A and B). However, the expression of Vps35 WT-
GFPwithAPEX-GBP resulted in specific and enriched electron
density at the site of morphologically identifiable endosomes
(Fig. 3C). Vps35 P316S-GFP was enriched at endosomes and
present on the external leaflet of endosomes, analogous to the
WT (Fig. 3D). Vps35 R524W-GFP, when co-transfected with
APEX-GBP, had reduced enrichment at the cytosolic face of
endosomes and an increase in the abundance of soluble reac-
tion product (Fig. 3E), resembling the expression of APEX-GBP
alone andGFPAPEX-GBP. As an additional positive control,
we analyzed the distribution of Vps35 D620N-GFP, a point
mutant that we have previously demonstrated generates an
enlarged and clustered endosomal network. Strikingly, this
mutant resulted in specific reaction product at enlarged and
morphologically distinct endosomes and a reduction of the sol-
uble pool of the protein (Fig. 3F).
The Association of Vps35 R524W with Regulators of the Ret-
romer Complex Is Impaired—Retromer does not bind directly
to membranes, and its recruitment to endosomes is controlled
by its capacity to coordinate interactions with a number of
membrane-associated proteins. Association of the retromer
complex with the endosomal membrane is positively regulated
by the small GTPase Rab7a and negatively regulated by the
RabGAP TBC1D5 (24). Following recruitment to the endo-
some, additional retromer-dependent sorting machinery, such
as the Arp2/3-activating complex,WASH, is recruited to aid in
FIGURE 1.Parkinsondisease-linkedVps35mutants P316S andR524Wdonot disrupt trimer formation.A, isothermal titration calorimetry of Vps35 point
mutations with retromer subunits, Vps29 (left) and Vps26A (right). B and C, GFP-NanoTrap immunoprecipitations from HeLa cell whole cell lysates (B) or
cytosolic subcellular fractions (C) of transiently expressing GFP, Vps35WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP followed by immunoblotting analysis
of precipitated complexeswith anti-GFP, anti-Vps26A, and anti-Vps29 antibodies.D, endogenous Vps26Awas immunoprecipitated fromHeLa cells transiently
expressing GFP, Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP followed by immunoblotting analysis of precipitated complexes with anti-Vps35,
anti-Vps26A, and anti-Vps29 antibodies. Within the control lane the same experimental procedure was applied in the absence of the primary anti-Vps26A
antibody.
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cargo sorting (25–27). We examined the subcellular localiza-
tion of the WASH complex subunit FAM21, Rab7a, and
TBC1D5 and their ability to interactwith the retromer complex
via co-immunoprecipitation following expression of Vps35
P316S-GFP and Vps35 R524W-GFP. HeLa cells transiently
expressing GFP fusion constructs were fixed and immunola-
beled with antibodies against endogenous FAM21 (Fig. 4A),
Rab7a (Fig. 4D), and TBC1D5 (Fig. 4G). Consistent with previ-
ous findings, Vps35 WT-GFP or Vps35 P316S-GFP demon-
strated a high level of co-localization (RWT 0.8900 andRP316S
0.9035; Fig. 4B) in contrast to cells expressing Vps35 R524W-
GFP, where a significant decrease in co-localization with
FAM21 (RR524W  0.8011; Fig. 4B) was observed. Similar to
this, HeLa cells expressing Vps35 WT-GFP or Vps35 P316S-
FIGURE 2. Vps35 R524W disrupts recruitment of retromer to the endosomal membrane. A, confocal analysis of HeLa cells transiently expressing Vps35
WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP immunolabeled with anti-Vps26A (n 3, 10 images/group). Scale bar, 5m. B, representative immunoblot-
ting (n 4) of HeLa cells transiently expressing Vps35WT-GFP, Vps35 P316S-GFP, or Vps35 R524W subjected to fractionation, SDS-PAGE, and immunolabeling
with antibodies against the listed proteins. C, representative immunofluorescence images of HeLa cells transiently expressing Vps35 WT-GFP, Vps35 P316S-
GFP, or Vps35R524W-GFP labeledwith EEA1or LAMP1 followedby counterstainingwithDAPI. Scale bar, 5m.D, analysis of co-localization from c represented
by Pearson’s correlation coefficient. Graphs representative of three independent experiments with 10 images/group with 5–7 transfected cells/field of view
(error bars, S.E.; *, p 0.05; ns, not significant; ANOVA with Tukey’s multiple comparison test).WCL, whole cell lysate.
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GFP immunolabeledwith antibodies against Rab7a or TBC1D5
displayed a moderate but consistent amount of co-localization
(Rab7a, RWT  0.2828 and RP316S  0.2856; TBC1D5, RWT 
0.2967 and RP316S  0.2820; Fig. 4, E and H, respectively). In
contrast to these observations, expression of Vps35 R524W
revealed a marked decrease in overlap with both Rab7a and
TBC1D5 (RR524W 0.2166 and RR524W 0.2056; Fig. 4, E and
H, respectively). Further, consistent with the previously
described LAMP1 immunolabeling (Fig. 2C), Rab7a-positive
endosomes demonstrated swelling following expression of
FIGURE 3. Ultrastructural resolution of Vps35-GFP. A, HeLa cells transfected with APEX-GBP alone demonstrate strong electron-dense reaction product in
the cytoplasm. B, EGFP co-transfected with APEX-GBP results in exclusively cytoplasmic electron density. C, Vps35 WT-GFP  APEX-GBP demonstrates
significant electron density at the endosomes of transfected cells. Arrows, endosomeswith increased electron density comparedwith the cytoplasm.D, Vps35
P316S-GFP closely resembles theWT construct. Arrows, endosomeswith increased electron density when comparedwith the cytoplasm. E, Vps35 R524W-GFP
demonstrated a reduction in endosome association and an increase in soluble reaction product. Arrows, endosomes with enriched electron density over the
cytoplasm; arrowheads, endosomes without electron density. F, Vps35 D620N-GFP caused enlarged endosomes with strong reaction product in transfected
cells. *, untransfected adjacent cells. Scale bars, 1 m.
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Vps35 R524W, but not Vps35 P316S or Vps35 WT, whereas
endosomes positive for FAM21 or TBC1D5 displayed no evi-
dence of gross morphological changes or differences in subcel-
lular localization when compared with Vps35 WT-GFP or
Vps35 P316S-GFP expression.
Co-immunoprecipitation was employed to investigate the
ability of Vps35 P316S- and Vps35 R524W-containing retro-
mer to interact with, FAM21, Rab7a, and TBC1D5 (Fig. 4).
HeLa cells expressing GFP fusion constructs were lysed, and
protein complexes were immunoprecipitated usingGFPNano-
Trap, resolved by SDS-PAGE, and identified using Western
blotting technique. Using antibodies against GFP and endoge-
nous FAM21, Rab7a, and TBC1D5, no differences in the ability
of Vps35 P316S-GFP-containing retromer to interact with
FAM21, Rab7a, or TBC1D5 were observed, as determined by
comparison with the levels of co-precipitated protein using
Vps35 WT-GFP (Fig. 4, C, F, and I, respectively). In contrast,
Vps35 R524W-GFP demonstrated a clear reduction in its
capacity to co-precipitate FAM21, Rab7a, andTBC1D5, despite
the total levels of all proteins being similar. Overall, Vps35
R524W consistently shows a decreased level of recruitment to
endosomes, which is reflected in a lower level of interaction
with proteins known to function in its recruitment to mem-
branes. To determine whether the expression of Vps35 R524W
FIGURE 4. Vps35 R524W has diminished association with regulators of retromer. A, immunofluorescence staining of FAM21 in HeLa cells transiently
expressing Vps35 WT-GFP, Vps35 P316S-GFP, and Vps35 R524W-GFP followed by DAPI counterstaining. Scale bar, 5 m. B, analysis of co-localization from A
represented by Pearson’s coefficient. Graphs representative of three independent experiments with 10 images/group with 5–7 transfected cells/field of view
(error bars, S.E.; *, p  0.05; ns, not significant; ANOVA with Tukey’s multiple comparison test). C, representative co-immunoprecipitation (IP) of GFP, Vps35
WT-GFP, Vps35 P316S-GFP, and Vps35 R524W-GFP with endogenous FAM21 from HeLa cells. D, representative immunofluorescence images of HeLa cells
transiently expressing Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP labeled with late endosome marker, Rab7. Scale bar, 5 m. E, analysis of
co-localization from D represented by Pearson’s coefficient. Graphs are representative of three independent experiments with 10 images/group with 5–7
transfected cells/field of view (error bars, S.E.; *, p 0.05; ns, not significant; ANOVA with Tukey’s multiple comparison test). F, representative co-immunopre-
cipitation of GFP, Vps35 WT-GFP, Vps35 P316S-GFP, and Vps35 R524W-GFP with endogenous Rab7a from HeLa cells. G, localization of TBC1D5 in HeLa cells
expressing Vps35WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP counterstainedwithDAPI. Scale bar, 5m.H, analysis of co-localization fromG represented
byPearson’s coefficient.Graphs representativeof three independent experimentswith10 images/groupwith5–7 transfectedcells/fieldof view (error bars, S.E.;
*, p 0.05; ns, not significant; ANOVAwith Tukey’s multiple comparison test). I, representative Western blots of TBC1D5 co-immunoprecipitation with Vps35
WT-GFP-, Vps35 P316S-GFP-, or Vps35 R524W-GFP-containing retromer from HeLa cells.
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was interfering with recruitment of these retromer-interacting
proteins, we examined the level of co-localization between
endogenous Vps26A and TBC1D5. A non-significant change
was observed between control cells and those expressing the
Vps35-GFP proteins (data not shown), consistent with these
PD-associated Vps35 variants not interfering with endogenous
retromer recruitment.
Vps35 R524WExpression Induces -Synuclein Aggregation—
Next, we employed the recently described retromer-stabilizing
agent (28) R55 in an attempt to rescue the diminished mem-
brane recruitment of Vps35 R524W-GFP-containing retromer.
For this, we employed both immunofluorescence and biochem-
ical methodologies described above. HeLa cells transiently
expressing Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35
R524W-GFP were incubated with 5 M R55 or DMSO control
for 48 h, fixed, and immunolabeled with the early endosomal
marker, EEA1. As previously observed (Fig. 2C), in cells incu-
bated with DMSO vehicle control, co-localization analysis
between GFP and EEA1 showed a decrease in Vps35 R524W-
GFP at the early endosome (RWT 0.214, RP316S 0.213, and
RR524W  0.158; Fig. 5, A and B). Interestingly, treatment of
cells transfected with Vps35 R524W-GFP and treated with R55
agent demonstrated an increased endosomal localization (Fig.
5, A and B, RWT 0.269, RP316S 0.271, and RR524W 0.211).
In agreement with this observation, biochemical fractionation
of cells transfected with GFP, Vps35 WT-GFP, Vps35 P316S-
GFP, or Vps35 R524W-GFP showed an increase in the total
level of Vps35 WT-GFP and Vps35 P316S-GFP and a marked
shift of Vps35 R524W-GFP from the cytosolic to microsome
fraction (Fig. 5C). However, the presence of R55 did not com-
pletely rescue the loss of Vps35 R524W-GFP in the microsome
fraction to a level equivalent to that observed for Vps35 WT-
GFP or Vps35 P316S-GFP (Fig. 5C).
-Synuclein is the major component of LBs, a prominent
phenotype in PD pathogenesis. Although the underlying cause
of LB formation is not fully understood, it appears to be caused
by the perturbation of several distinct cellular homeostasis pro-
cesses, including defects in endosomal degradation pathways
(29, 30). To address whether retromer plays a role in the accu-
mulation of aggregated-synuclein, we used the SH-SY5Yneu-
roblastoma cell model, which endogenously expresses -sy-
nuclein, possesses machinery needed for dopamine uptake and
metabolism, and responds to external stimuli, including depo-
larization using KCl (31). To confirm the suitability of this
assay, the induced -synuclein aggregates were confirmed to
contain phosphorylated -synuclein (32), autophagy compo-
FIGURE 5. Pharmacological stabilization of retromer increases its total levels and membrane recruitment. A, confocal images of HeLa cells transiently
expressing Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP incubated with DMSO or 5 M R55 immunolabeled with EEA1 and counterstained with
DAPI. Scale bar, 5m. B, graphical representation of co-localization observed in A from two independent experiments with 10 images per construct and time
point. Error bars, S.E.; *, p  0.05; ns, not significant; ANOVA followed by Tukey’s multiple comparison test. C, representative Western blots of HeLa cells
transiently expressing GFP, Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP treated with 5 M R55 or DMSO for 48 h (n 3). Membranes were also
analyzed using anti-LAMP1 for a loading control.
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nent p62 (32, 33), and lysosome marker, LAMP1 (34) (Fig. 6A).
These aggregates are also thioflavin-S-positive, indicating that
some of the aggregated -synuclein is in a fibrillary form (Fig.
6A). Furthermore, the ability of this method to induce higher
molecular weight aggregates of GFP--synuclein was con-
firmed biochemically (Fig. 6B). All of these properties have
been associated with -synuclein aggregates formed in other
Parkinson disease models and/or Lewy bodies.
The reduced recruitment of Vps35 R524W to endosomes
would impair the retromer’s function; therefore, the expression
of this Vps35 PD-associated mutant may reduce -synuclein
clearance and promote aggregation. Untransfected SH-SY5Y
cells and cells expressing GFP, Vps35WT-GFP, Vps35D620N-
GFP,Vps35 P316S-GFP, orVps35R524W-GFPwere incubated
with 50 mM KCl for 60 min and allowed to recover in complete
growth medium for 48 h and immunolabeled for endogenous
-synuclein, and transfected cells were scored as positive or
negative for aggregates. -Synuclein-positive aggregates were
observed in 7.2% of untransfected SH-SY5Y cells, 13% of
SH-SY5Y cells expressing GFP, and 20% of those expressing
FIGURE 6. Parkinson disease-linked Vps35 point mutations increase the production of -synuclein-positive aggregates. A, SH-SY5Y cells were
untreated or were induced by KCl treatment to form -synuclein aggregates (arrows), and immunofluorescence was performed with anti--synuclein in
combination with antibodies to phosphorylated -synuclein (phospho-Ser-129), autophagy marker p62, lysosome marker LAMP1, and protein aggregation
marker thioflavin-S. Scale bar, 2 m. B, SH-SY5Y cells stably expressing GFP alone or GFP--synuclein were depolarized with 50 mM KCl for 60 min or sham-
treated and left to recover for 48 h. Soluble and insoluble fractions were generated and analyzed by Western blotting as described under “Experimental
Procedures.” 40 g of protein was loaded in each lane. A higher exposure (High Ex.) of the GFP--synuclein is shown, whereas the lower exposure (Low Ex.) is
equivalent to the soluble fraction. C, confocal immunofluorescence images of SH-SY5Y cells expressing GFP fusion constructs, immunolabeled with anti--
synuclein, and counterstainedwithDAPI following treatmentwith KCl. Scale bar, 5m.D, graph representing the number of transfected SH-SY5Y cells bearing
-synuclein aggregates following KCl treatment before incubation with DMSO or 5 M R55 for 48 h. The graph represents the proportion of cells with
-synuclein aggregated from 20–30 random images from three independent experiments. Error bars, S.E.; *, p 0.05; ns, not significant; ANOVA followed by
Tukey’s multiple comparison test.
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Vps35WT-GFP. In comparisonwith these control cells, 29% of
Vps35 P316S-GFP-expressing cells, 43% of Vps35 R524W-
GFP-expressing cells, and 56% of Vps35 D620N-GFP-express-
ing cells were observed to have-synuclein aggregates (Fig. 6,C
and D). Concurrent treatment of untransfected SH-SY5Y cells
with 5 M R55 for 48 h resulted in a consistent reduction in the
total percentage of aggregates observed (4%) (Fig. 6D). Like-
wise, a reduction in the total number of aggregates was wit-
nessed in R55-treated SH-SH5Y cells expressing GFP or Vps35
WT-GFP (9 and 15%, respectively). This trend was also
observed for SH-SY5Y cells expressing either Vps35 P316S-
GFP (21%) or Vps35 R524W-GFP (33%); however, this was not
seen in cells expressing Vps35 D620N-GFP (50.2%; Fig. 6D),
potentially due to its nature as a likely dominant negative pro-
tein. Therefore, the expression of these PD-associated Vps35
mutants can directly influence the formation of large -sy-
nuclein-positive aggregates, a hallmark of PD.
Retrograde Sorting Is Delayed in the Presence of Vps35
R524W—To test the functional impact of Vps35 R524W
expression on the retrograde endosomal cargo sorting, we
investigated the recycling of the well characterized retromer
cargo, CI-M6PR. Previous reports mapped the interaction
between retromer and the cytosolic tail of the CI-M6PR to
amino acids 500–693 of the Vps35 subunit (11). Given the
location of the point mutations on the Vps35 in relation to the
Vps29 and the cargo-interacting domain within Vps35,
the interaction of retromer with CI-M6PR, modulation of sol-
uble lysosomal enzyme delivery, relative co-localization, and
kinetics of retrograde trafficking were analyzed as described
previously (10, 11, 17). Vps35 P316S-containing retromer was
found to co-precipitate the M6PR at levels identical to that of
the wild-type retromer, whereas Vps35 R524W displayed de-
creased levels ofM6PR (ranging from 15 to 60% less precipitant
than Vps35 WT levels) (Fig. 7A). Expression of Vps35 P316S-
GFP, like Vps35WT-GFP, did not disrupt the lysosomal deliv-
ery of cathepsin D, which is dependent on mannosylation and
binding to the CI-M6PR for the transport of the Golgi-pro-
cessed precursor into the endosomal system. In contrast,
expression of Vps35 R524W-GFP clearly disrupted the traffick-
ing itinerary of the CI-M6PR because secretion of pro-cathep-
sin D into the extracellular medium was observed after protein
synthesis was inhibited for 7 h (Fig. 7B). Next, the subcellular
distribution of the endogenous CI-M6PR relative to retromer
was examined. The CI-M6PR was localized to punctate and
perinuclear organelles in cells transfectedwithVps35WT-GFP
and Vps35 P316S-GFP and demonstrated a small amount of
overlap with retromer (RWT 0.210 and RP316S 0.204; Fig. 7,
C andD). In comparison, expression of Vps35 R524W-GFPwas
found to alter the subcellular distribution of the CI-M6PR from
predominantly perinuclear staining to dispersed puncta. These
dispersed CI-M6PR-positive puncta demonstrated increased
co-localization with the Vps35 R524W-GFP endosomal retro-
mer (RR524W  0.261) relative to controls. Given the observed
deficit in retrograde trafficking, we investigated the Golgi mor-
phology in HeLa cells transfected with all GFP constructs using
antibodies against trans-Golgi protein, p230. HeLa cells
expressing the described constructs demonstrated no marked
differences in overall Golgi morphology or distribution (data
not shown).
HeLa cells were co-transfected with CD8-CI-M6PR to mon-
itor the retrograde delivery of internalized antibodies to the
TGN using a well established antibody uptake assay (10). Cells
were incubated on ice with anti-CD8 antibody and chased at
37 °C for up to 30 min. In cells expressing CD8-CIM6PR and
GFP only, strong CD8 immunostaining was observed onmem-
branes positive for p230, demonstrating efficient delivery of the
reporter to the TGN network following retromer-mediated
transport through the endosome. Consistent with this, strong
CD8 immunostaining was observed to overlap with p230-pos-
itive membranes in cells expressing either Vps35 WT-GFP or
Vps35 P316S-GFP at 30 min post-chase (Fig. 7E). However, in
cells expressing Vps35 R524W-GFP, the majority of the p230-
positivemembranes did not display evidence of CD8 staining at
30 min post-chase and showed strong CD8-CIM6PR localiza-
tion to dispersed punctate structures, reminiscent of endo-
somes, indicative of significant delays in the retrograde sorting
pathway (Fig. 7E). Based on these multiple assays, the expres-
sion of the PD-associated Vps35 R524Wmutant retromer pro-
tein significantly impacts the retrograde trafficking pathway
and accumulates CI-M6PR in endosomes due to an inefficiency
in transporting proteins from endosomes to the TGN.
SNX27 (Sorting Nexin 27)-Retromer-dependent Recycling of
GLUT1 Is Unaffected in the Presence of Vps35 R524W—In addi-
tion to retrograde trafficking of cargo, retromer also functions
to recycle proteins from endosomes to the plasma membrane
by forming a complex with SNX27 (35, 36). To determine
whether Vps35 P316S-GFP or Vps35 R524W-GFP expression
impacts the retromer-mediated recycling pathway, we investi-
gated the subcellular localization of endogenous SNX27 in
transfectedHeLa cells (Fig. 8,A andB). Co-localization analysis
revealed amoderate overlap between bothVps35WT-GFP and
SNX27 (r  0.3562) and Vps35 P316S-GFP with SNX27 (r 
0.3851), whereas analysis of Vps35 R524W-GFP with SNX27
demonstrated a marked reduction in co-localization (r 
0.2659; Fig. 8B). Membrane fractionation showed unchanged
levels of SNX27 recruited to membranes (data not shown), and
the subcellular localization relative to endogenous Vps26A
(Fig. 8C) and overall, the SNX27-positive endosome morphol-
ogy in the presence of Vps35 R524W-GFP was unaltered (Fig.
8A), consistent with the notion that SNX27 is recruited to the
endosome independent of the retromer complex. Relative to
Vps35WT-GFP, less SNX27 was co-immunoprecipitated with
Vps35 R524W-GFP (Fig. 8D). To determine whether this
decrease in SNX27 binding to Vps35 R524W retromer had a
dominant negative effect on the recycling pathway as it does for
the retrograde pathway, we analyzed GLUT1 as a representa-
tive and well established SNX27-retromer-dependent cargo
(36, 37). HeLa cells expressing Vps35 WT-GFP, Vps35 P316S-
GFP, or Vps35 R524W-GFP were immunolabeled with anti-
bodies raised against endogenous GLUT1 and LAMP1 (Fig.
8E). Confocal microscopy revealed localization of GLUT1 to
both the cell surface and punctate structures in cells expressing
Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP,
reminiscent of the neighboring untransfected cell staining.
Additionally, intracellular localization of GLUT1 demon-
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strated minimal overlap with late endosome marker, LAMP1,
supporting uninterrupted recycling in the presence of Vps35
P316S-GFPorVps35R524W-GFP (Fig. 8E). To further confirm
these results, we labeled the plasma membrane of transfected
cells with biotin and used streptavidin-based precipitation to
assess the cell surface levels of GLUT1 and TfnR. Biotinylation
revealed similar cell surface levels of retromer-dependent
cargo, GLUT1, and retromer-independent receptor, TfnR, in
cells expressing GFP, Vps35 WT-GFP, Vps35 P316S-GFP, or
Vps35 R524W-GFP.We also found that Vps35 D620N expres-
sion did not impact recycling of GLUT1 (Fig. 8F), consistent
with previous reports (19). In support of this finding, HeLa cells
expressing all GFP fusion constructs demonstrated identical
levels of glucose uptake compared with controls, which was
consistent with GLUT1 biotinylation observations (Fig. 8G).
Therefore, the reduced levels of Vps35 R524W-GFP from
SNX27-positive endosomes do not appear to negatively impact
the recycling function of retromer.
Discussion
Although the PD-linked point mutation Vps35 P316S does
not destabilize the retromer’s high affinity trimer structure,
Vps35 R524Wdisplayed some evidence of impaired trimer for-
mation,modulation of retromer’s cellular functions, and induc-
tion of -synuclein aggregation, which is an underlying hall-
mark of PD. Despite genetic evidence linking this mutation to
FIGURE 7. Expression of Vps35 R524W perturbs localization and sorting of CI-M6PR. A, representative co-immunoprecipitation of GFP fusion constructs
with CD8-M6PR reporter resolved by SDS-PAGE. Membranes were immunolabeled with anti-CD8. B, representative immunoblots of culture medium and cell
lysates fromHeLa cells transiently transfected with Vps35WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP and incubated with 100g/ml cyclohexamide for
up to 7 h (n 3). Membranes were probed with antibodies raised against -tubulin and cathepsin D. C, confocal analysis of HeLa cells transiently expressing
Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W immunolabeled with antibodies against endogenous CI-M6PR and counterstained with DAPI. Scale bar, 5
m. D, graphical representation of co-localization observed in C. The graph represents three independent experiments with 10 images/group with 5–7
transfected cells/field of view (n 3; error bars, S.E.; *, p 0.05; ns, not significant; ANOVA followed by Tukey’s multiple comparison test). E, representative
images of HeLa cells expressing CD8-CIM6PR and GFP fusion constructs at 30 min post-chase with anti-CD8 and immunolabeled with anti-p230 (red) and
anti-CD8 (green) antibodies. Scale bar, 5 m.
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late onset PD, expression of Vps35 P316S did not display any
distinct cellular phenotypes when comparedwith expression of
Vps35 WT. Vps35 R524W demonstrated poor recruitment to
the endosome, and its incorporation negatively impacted the
interaction of retromer with several well established retromer-
interacting proteins. Further, this mislocalization of Vps35
R524W-containing retromer resulted in reduced endosome-
to-Golgi but not endosome-to-plasma membrane receptor
sorting. This was demonstrated by several CI-M6PR trafficking
assays, where we show the redistribution of endogenous
CI-M6PR from the perinuclear space to dispersed puncta, late
endosome swelling, and detectable levels of pre-cathepsin D in
the culture medium, which were mirrored by the decrease in
cathepsin D processing in the cells. Finally, we demonstrate
that expression of the R524Wmutation leads to increased lev-
els of -synuclein-positive aggregation.
Previous studies demonstrate the recruitment of additional
endosomal machinery, such as the WASH complex, TBC1D5,
and members of the SNX-BAR, to the endosome assist retro-
mer in mediating sorting of its cargo to the TGN (20, 38, 39).
However, it is the combination of the small GTPase Rab7a and
phox homology (PX)-containing protein SNX3 that is thought
to initiate this cascade by recruiting retromer to the membrane
(24, 40). The current view of retromer mediated transport is
FIGURE 8. Vps35 R524W does not disrupt SNX27-dependent cargo recycling. A, immunofluorescence of HeLa cells transiently expressing Vps35WT-GFP,
Vps35 P316S-GFP, or Vps35 R524W-GFP immunolabeledwith anti-SNX27. Scale bar, 5m. B, graphical representation of co-localization observed in A. Graphs
are representative of three independent experiments with 10 images/group with 5–7 transfected cells/field of view (error bars, S.E.; *, p  0.05; ns, not
significant; ANOVA followedbyTukey’smultiple comparison test).C, Pearson’s coefficient of SNX27withVps26A inHeLa cells expressingVps35WT-GFP, Vps35
P316S, or Vps35 R524W-GFP (error bars, S.E.; *, p 0.05; ns, not significant; ANOVA followed by Tukey’s multiple comparison test).D, co-immunoprecipitation
(IP) using GFP NanoTrap of GFP, Vps35 WT-GFP, Vps35 P316S-GFP, and Vps35 R524W-GFP with endogenous SNX27. E, representative immunofluorescence
images of HeLa cells expressing Vps35 WT-GFP, Vps35 P316S-GFP, or Vps35 R524W-GFP followed by co-immunolabeling with anti-GLUT1 and anti-LAMP1.
Scale bar, 5 m. F, representative Western blots (n 3) of HeLa cells expressing GFP fusion constructs showing biotinylation of cell surface and total GLUT1
levels.G, graphical demonstrationof glucose uptake inHeLa cells transiently transfectedwithGFP fusion constructs.ns, not significant. Data are representative
of three independent experiments conducted in triplicate. Error bars, S.E.
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that the Vps35-Vps26-Vps29 proteins form a stable core trimer
that is a hub for associating with regulatory and cargo proteins
(25). Our data show that although the core complex remains
unaffected by the P316S, the R524W mutation partially dis-
rupts this formation and also negatively impacts the association
with regulatorymolecules needed for cargo sorting. Previously,
Vps35-Rab7a-SNX3 interaction studies demonstrated that
binding of Rab7a and SNX3 is within the first 300 amino acids
of Vps35 and immediately adjacent to the Vps26-Vps35 inter-
face (41). Despite this, we showed that R524W, but not the
P316S mutation within Vps35, severely impacts the retromer-
Rab7a interaction and Vps35 R524W-retromer membrane
association, coupled with reduced interactions with theWASH
complex subunit FAM21, the RabGAP TBC1D5, and PDZ
motif cargo adaptor SNX27.Whereas Vps35 R524W-retromer
displayed impaired binding to multiple retromer-associated
proteins, we suggest that this is a consequence of reduced endo-
some recruitment rather than a direct impact on the binding
surfaces of all of thesemolecules. Interestingly, the use of R55, a
recently described retromer-stabilizing agent (28), showed a
rescue phenotype in membrane association of the Vps35
R524W-retromer, possibly by stabilizing a conformational
change needed for retromer-Rab7a interaction required for
membrane recruitment. Therefore, these findings suggest that
the observed defect in Vps35 R524W-expressing cells arises
from its diminished interaction with machinery needed to
recruit retromer to the membrane, second to a partial loss of
stable incorporation into the retromer trimer.
Given the described role of CI-M6PR in trafficking of cathep-
sin D, a protease needed for clearance of -synuclein (42, 43),
and the importance of retromer in correct localization of the
CI-M6PR and sorting of lysosomal cathepsin D (11, 13, 44), it is
not unexpected that expression of Vps35 mutants that perturb
trafficking demonstrates increased frequency of forming intra-
cellular aggregates. Additionally, a complete knock-out of
cathepsin D leads to extensive levels of high molecular weight
-synuclein species and an increase in Lewy Body numbers in
brains of knock-out animals (30). Together, these findings sup-
port the concept that regulation of the lysosomal pathway and
its lumenal content plays a fundamental role in turnover of
proteins, a pathway that is already highly susceptible to errors
during aging (45). To examine the role of retromer in -sy-
nuclein aggregation and clearance, we used a non-pharmaco-
logical based stimulus (KCl) rather than other reagents (Rote-
none, Bafilomycin A1) that target mitochondrial and lysosomal
function, respectively, andmay indirectly impact the retromer’s
cellular function (46, 47). Using this assay, our findings indicate
that the expression of Vps35 R524W leads to CI-M6PR and
cathepsin D mistrafficking, suggesting a direct correlation
between the loss of retromer, the Vps35 R524W point muta-
tion, and the production of -synuclein aggregates in a cellular
system. Consistent with these results, the previously described
PD-linked Vps35 mutation (Vps35 D620N) was also reported
to impair the degradation of -synuclein, a product of dimin-
ished endolysosomal functionality, further supporting a rela-
tionship between receptor trafficking and -synuclein aggre-
gate production (21). Several lines of evidence also demonstrate
the requirement of bothRab7 andTBC1D5 inmaintaining con-
stant autophagic flux, retromer-dependent trafficking, and
optimal function of the lysosomal compartment (30, 38,
48–50). Although these studies do not conclusively demon-
strate a direct link between the retromer complex, autophagic
flux itself, and formation of -synuclein aggregates, they
do support the emerging notion that retromer-dependent
machinery is required for functionality of the endolysosomal-
autophagy clearance pathways.
The interaction between the SNX27 PDZ domain and the
Vps26 subunit of the retromer complex has been shown to be
important in regulation of the recycling pathway (37), but their
recruitment to the endosomal membrane appears to be inde-
pendent of each other (36). Here we confirm that the mem-
brane association of SNX27 is not impaired in the presence of
Vps35 R524W expression and also demonstrate that recycling
of GLUT1, a known PDZmotif-containing cargo, was identical
to that observed in the presence of Vps35WT-GFP expression.
This may be due to the interaction of the endogenous SNX27
with the more abundant, endogenous retromer over the poorly
recruited Vps35 R524W-retromer leading to the uninterrupted
recycling of SNX27-dependent cargo observed here. Therefore,
the PD-linked R524W mutation does not influence the recy-
cling trafficking pathway in our experimental conditions, like
the PD-linked Vps35 D620N mutation, which appears to be
similarly functional in GLUT1 recycling.
Overall, we have demonstrated that Vps35 R524W-contain-
ing retromer poorly interacts with known endosomal machin-
ery and consequently impacts the retrograde cargo sorting
properties of the retromer complex and not its role in recycling
SNX27-dependent cargo. Expression of Vps35 R524W is
similar to the sorting defect witnessed for the Vps35 D620N
mutation linked to PD, in which the CI-M6PR is not efficiently
delivered to the TGN (7, 17, 19). However, Vps35 D620N-con-
taining retromer reportedly interacts with accessory proteins
TBC1D5 and SNX27, to the same degree as wild-type retromer,
but has minor reductions in its ability to interact with the
WASH complex (19, 21), whereas Vps35 R524W has reduced
interactions with TBC1D5, SNX27, and the WASH complex.
Vps35 D620N broadly modifies endosome morphology (17),
whereas Vps35 R524W expression alters late endosome mor-
phologywithminimal enrichment at the endosome, supporting
very distinct changes to themolecular and cellular properties of
the retromer sorting pathways in the presence of the twomuta-
tions. Despite these described differences between the D620N
and R524W Vps35 PD-linked mutations, it is clear that the
retrograde sorting properties of retromer, and not its role in
endosome to plasma membrane trafficking, are indeed
defective in PD. Although this does not rule out Vps35 P316S
as being causative in PD, it implies that the primary defect
leading to disease onset may be through a currently unde-
fined retromer-dependent mechanism.
Experimental Procedures
DNAConstructs—Vps35WT-GFP has been described previ-
ously (17) and was used to generate P316S and R524W point
mutations. QuikChange mutagenesis (Stratagene) was em-
ployed using the following PCR mutagenic primer pairs:
5-GCTCACCGTGAAGATGGATCCGGAATCCCAGCG-
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GAT and 3-ATCCGCTGGGATTCCAGGACCATCTT-
CACGGTGAGC or 5-GCTGGTGGAAATCAGTGGATT-
CGCTTCACACTG and 3-CAGTGTGAAGCGAATC-
CACTGATTTCCACCAGC, respectively. The pCMU-CD8/
CI-M6PR and Vps35 D620N-GFP constructs were described
previously (17).
Antibodies—The following primary antibodies were pur-
chased as indicated: mouse monoclonal anti-CIM6PR, anti--
synuclein, anti-SNX27 (C16), rabbit polyclonal anti-GLUT1,
anti-SQSTM1/p62, anti-Vps26A, and rabbit monoclonal anti-
-synuclein (phospho-Ser-129) (Abcam); mouse monoclonal
anti-GFP and rabbit polyclonal anti-GFP (Life Technologies,
Inc., and Roche Applied Science, respectively); goat polyclonal
raised against Vps35 (IMGENEX); mouse monoclonal anti-hu-
man EEA1, p230, and LAMP1 (BDTransduction Laboratories);
rabbit monoclonal anti-Rab7a (Cell Signaling); mouse mono-
clonal anti-CD8 (eBioscience); mouse monoclonal anti--tu-
bulin (Sigma-Aldrich); sheep polyclonal anti-TGN-46 (AbD
Serotec); goat polyclonal anti-TBC1D5 (C-14) (Santa Cruz Bio-
technology); and rabbit polyclonal anti-cathepsin D and anti-
FAM21C (Merck Millipore). Rabbit polyclonal against Vps29
was generated in house and used previously (10). Secondary
goat anti-mouse IgG Alexa Fluor 568, donkey anti-mouse IgG
Alexa Fluor 546, and donkey anti-goat IgG Alexa Fluor 647
were from Life Technologies; horseradish peroxidase-conju-
gated anti-rabbit and anti-mouse antibodies were from Dako;
and IRdye 680- and IRdye 800-conjugated fluorescence second-
ary antibodies were from LI-COR Biosciences.
Cell Culture and Transfection—HeLa cells were grown in a
humidified 37 °C incubator with 5% CO2 and maintained in
DMEM supplemented with 10% FBS (Gibco) and 2 mM L-glu-
tamine (Life Technologies). SH-SY5Y cells (Sigma-Aldrich)
were maintained in Roswell Park Memorial Institute (RPMI)
medium supplemented with 10% FBS (Gibco) and 2 mM L-glu-
tamine (Life Technologies).Mammalian constructs were trans-
fected into cells using Lipofectamine 2000 (Life Technologies)
according to the manufacturer’s instructions. This routinely
achieved 50–70% transfection efficiency for HeLa cells and
25–40% for SH-SY5Y cells.
Protein Purification and ITC—Constructs of mouse VPS35,
VPS29, and VPS26A for expression in Escherichia coli were
described previously (17), and all VPS35 point mutations were
engineered using the QuikChange mutagenesis kit (Strat-
agene). Recombinant proteins used for the ITC experiments
were prepared and analyzed as described (51). Experiments
were performed in 20 mM Tris (pH 8.0), 200 mM NaCl, 1 mM
DTT at 283 K using a MicroCal iTC200 (GE Healthcare).
Immunoprecipitations—Transfected HeLa cell monolayers
werewashed in ice-cold PBS and lysed inTK lysis buffer (50mM
HEPES, 150 mM NaCl, 1% Triton X-100, 10 mM Na4P2O7, 30
mM NaF, 2 mM Na3VO4, 10 mM EDTA, 0.5 mM AEBSF, and
CompleteMini protease inhibitor mixture (Roche Applied Sci-
ence)) for 10 min on ice. Whole cell lysates were centrifuged at
17,000 g, and supernatant was collected. These supernatants
were incubated with GFP-NanoTrap beads for 1–2 h or anti-
Vps26A antibodies overnight at 4 °C under constant rotation.
Vps26A antibodies were complexed by the addition of Protein
G-Sepharose beads. GFP immunoprecipitation performed
from isolated cytosol was conducted in HES buffer described
below. Complexes were dissociated from the beads by boiling
after three consecutive washes with TK lysis buffer.
Western Immunoblotting—Cell lysate samples were sub-
jected to a bicinchoninic acid (BCA) assay (Thermo Scientific)
to determine protein concentration. Equivalent amounts of
protein per sample (10–50 g) were resolved by SDS-PAGE
and transferred onto PVDF membrane (Immobilon-P and
Immobilon-FL, Millipore) according to the manufacturer’s
instructions. Immunoblotting using ECL and the Odyssey
infrared imaging system (LI-COR) was performed as per the
manufacturer’s instructions.
ElectronMicroscopy—EMwas performed as described previ-
ously (23). Briefly, HeLa cells were seeded onto 3-cmdishes and
transfected with a DNA ratio of 1:1 GFP-tagged protein of
interest to APEX-GBP using Lipofectamine 2000 (Invitrogen)
as per the manufacturer’s instructions. Cells were fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer for 1 h at
room temperature and washed repeatedly in 0.1 M sodium
cacodylate buffer. The diaminobenzoic acid reaction was per-
formed for 30 min at room temperature in the presence of
H2O2. Cells were then post-fixed in 1% osmium tetroxide for 2
min and then washed again in 0.1 M sodium cacodylate. Cells
were serially dehydrated in increasing percentages of ethanol
and subsequently serially infiltrated with increasing percent-
ages of LX112 resin and polymerized at 60 °C overnight. Ultra-
thin sections (60 nm) were cut on an Ultracut UC6 ultrami-
crotome (Leica) and on a JEOL 1011 electron microscope at 80
kV fitted with a Morada Soft Imaging camera (Olympus) at
2-fold binning.
Indirect Immunofluorescence, Confocal Microscopy, and Co-
localization Analysis—HeLa cells grown on glass coverslips
were washed with room temperature PBS twice before fixation
with 4% paraformaldehyde for 20 min. Cells were permeabi-
lized using 0.1% Triton X-100/PBS for 10 min at room temper-
ature and subsequently blocked using 2% BSA/PBS for 45 min.
Cells were labeled with primary and secondary antibodies and
counterstained with DAPI nuclear stain. Coverslips were
mounted using fluorescent mounting medium (Dako) and
imaged using a Zeiss LSM710 upright scanning laser confocal
fluorescent microscope equipped with a 63 plan-apochro-
matic objective and argon, HeNe1, HeNe3 lasers.
All images were analyzed using Zeiss LSM version 5.0 and
Adobe Photoshop software. Pearson’s correlation coefficients
were calculated using the ImageJ plugin “Colocalization finder”
(National Institutes of Health). Fields of view containing both
transfected and non-transfected cells were segregated by gen-
erating regions of interest around transfected cells, cropping
selected regions, splitting into respective grayscale channels,
and applying threshold settings. Co-localization analysis was
conducted on three independent experiments with 10 images/
group containing 5–10 transfected cells/field of view. Co-local-
ization values were exported to GraphPad Prism version 5 soft-
ware and tabulated accordingly.
Microsomal Fractionation—HeLa cells grown in 15-cm2 cul-
ture dishes were washed twice on ice in PBS, collected, and
homogenized with 20 passages through a 22-gauge 3⁄4 needle in
buffer containing 20mMHEPES, pH 7.4, 250mM sucrose, 1mM
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EDTA, 2 mM Na3VO4, 10 mM EDTA, and 0.5 mM AEBSF.
Lysates were spun at 500  g for 5 min, and a portion of the
resulting supernatant was collected and stored as the whole cell
lysate. The resulting supernatant was further centrifuged at
17,200  g for 20 min to isolate the crude plasma membrane
fraction followed by 175,000 g for 75min to isolate themicro-
some fraction from the remaining cytosolic fraction. Pelleted
microsomes were resuspended in homogenization buffer (20
mM HEPES, pH 7.4, 250 mM sucrose, 1 mM EDTA, 2 mM
Na3VO4, 10 mM EDTA, and 0.5 mM AEBSF).
-Synuclein Aggregation—SH-SY5Y cells grown on glass
coverslips were incubated with 50 mM KCl (Sigma-Aldrich) for
60min at 37 °C. Following the treatment, cells were either fixed
(0 h time point) or allowed to recover in complete growth
medium for up to 48 h, when they were fixed and immunofluo-
rescence microscopy was performed using anti--synuclein
antibody. For detection of -synuclein aggregates by Western
blotting, SH-SY5Y cells stably expressingGFP--synuclein (52)
were collected for analysis 48 h afterKCl treatment as described
(53) and resolved on a 6% SDS-PAGE to separate high molecu-
lar weight -synuclein. Thioflavin-S (Sigma-Aldrich) staining
was employed following washes with ethanol and performed as
described (54).
Cathepsin D Secretion Assay—HeLa cells plated in 6-well
dishes 48 h before use were washed in 37 °C PBS and incubated
with serum-free DMEM supplemented with 2 mM L-glutamine
and cyclohexamide (final concentration 100 g/ml). Medium
and cell lysate samples were collected at 0, 3, and 7 h post-chase
and centrifuged at 17,000 g for 10 min at 4 °C, and superna-
tants were transferred to fresh tubes. Collected medium was
precipitated using TCA for 10min on ice, boiled, and subjected
to Western blotting.
Antibody Uptake Assay—HeLa cells grown on glass cover-
slips were co-transfected with the previously described GFP/
CD8-CI-M6PR fusion constructs for 16 h. Transfected cells
were serum-starved in DMEM supplemented with 2 mM L-glu-
tamine for 4 h before being chased at 37 °C with anti-CD8 anti-
body. Post-chase coverslips were fixed in 4% PFA and subjected
to indirect immunofluorescence.
Cell Surface Biotinylation—16–18 h post-transfection,
transfected HeLa cells in 15-cm2 cell culture plates were
washed three times with ice-cold PBS, followed by incubation
with 0.25 mg/ml EZ-link Sulfo-NHS-LC-LC Biotin (Thermo
Fisher Scientific) for 10 min on ice, when reactions were
quenched by 50 mM glycine for 10 min. Cells were harvested in
TK lysis buffer, and protein concentrationswere determined by
a BCA protein quantitation assay. Equal amounts of protein
lysates were incubated with Neutravidin-agarose beads
(Thermo Fisher Scientific) for 1 h at 4 °C. After washing the
beads three times with TK lysis buffer, beads were boiled in 2
SDS sample loading dye, and pull-down sampleswere subjected
to SDS-PAGE/immunoblotting.
Glucose Uptake Assay—Transfected HeLa cells in a 12-well
platewerewashedwithwarmedKrebs-Ringer phosphate buffer
containing 10 mM HEPES, pH 7.4, 136 mM NaCl, 4.7 mM KCl,
1.25 mM CaCl2, 1.25 mM MgSO4, 0.6 mM Na2HPO4, 0.4 mM
NaH2PO4. Cell monolayers were incubated for 10 min in the
presence of 50 M 2-deoxy-D-glucose and 1 Ci/ml 2-deoxy-
[3H]glucose. The amount of glucose transported into the cells
was determined by harvesting the cells in 1% Triton X-100, and
the associated radioactivity was quantified using a MicroBeta
liquid scintillation counter (PerkinElmer Biosciences). The
counts/min were normalized to total protein concentrations.
Statistics—All statistical analyses were completed using
GraphPad Prism version 6 and are described in the appropriate
figure legends.
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